Mostrando 2 resultados de: 2
Cost-effectiveness of bendamustine versus fludarabine for first-line treatment of chronic lymphocytic leukemia (Cll) in Colombia
OtherAbstract: Objectives To determine the cost-effectiveness of bendamustine versus fludarabine for first line trePalabras claves:Autores:CARMEN BAYAS ZAMBRANOFuentes:googleThe Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment …
OtherAbstract: Objectives To determine the cost-effectiveness of bendamustine-rituximab (Ben-R) versus fludarabine-Palabras claves:Autores:CARMEN BAYAS ZAMBRANOFuentes:google